307 related articles for article (PubMed ID: 23261982)
21. Dickkopf-1 enhances migration of HEK293 cell by beta-catenin/E-cadherin degradation.
Kuang HB; Miao CL; Guo WX; Peng S; Cao YJ; Duan EK
Front Biosci (Landmark Ed); 2009 Jan; 14(6):2212-20. PubMed ID: 19273195
[TBL] [Abstract][Full Text] [Related]
22. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway.
Li M; Cai H; Yang Y; Zhang J; Sun K; Yan Y; Qu H; Wang W; Wang J; Duan X
Oncol Rep; 2016 Aug; 36(2):936-44. PubMed ID: 27277008
[TBL] [Abstract][Full Text] [Related]
23. Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination/degradation of β-catenin.
Wu L; Xiao J; Yi D; Ding H; Wang R; Duan Z; Liu Z; Shi X; Shen M; Sang J
J Transl Med; 2024 Feb; 22(1):201. PubMed ID: 38402159
[TBL] [Abstract][Full Text] [Related]
24. In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.
Zhang ZC; Liu JX; Shao ZW; Pu FF; Wang BC; Wu Q; Zhang YK; Zeng XL; Guo XD; Yang SH; He TC
Medicine (Baltimore); 2017 Jul; 96(27):e7245. PubMed ID: 28682874
[TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
[TBL] [Abstract][Full Text] [Related]
28. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of cell-adhesion molecules in histological variants of papillary thyroid carcinoma.
Andriescu EC; Căruntu ID; Giuşcă SE; Lozneanu L; Ciobanu Apostol DG
Rom J Morphol Embryol; 2018; 59(3):721-727. PubMed ID: 30534810
[TBL] [Abstract][Full Text] [Related]
30. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
[TBL] [Abstract][Full Text] [Related]
31. ANKRD22 knockdown suppresses papillary thyroid cell carcinoma growth and migration and modulates the Wnt/β-catenin signaling pathway.
Wu Y; Chen W; Zhang B; Liu H
Tissue Cell; 2023 Oct; 84():102193. PubMed ID: 37586180
[TBL] [Abstract][Full Text] [Related]
32. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
Kim HY; Park JH; Won HY; Lee JY; Kong G
FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
[TBL] [Abstract][Full Text] [Related]
33. KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathway.
Zhong J; Lin R; Wang G; Lin L; Ruan S; Liu W
Tissue Cell; 2022 Apr; 75():101739. PubMed ID: 35066335
[TBL] [Abstract][Full Text] [Related]
34. Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.
Yang M; Huang S; Zhao Y; Xie B; Hu X; Cai Y
Biochem Biophys Res Commun; 2023 May; 655():104-109. PubMed ID: 36934585
[TBL] [Abstract][Full Text] [Related]
35. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
36. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
[TBL] [Abstract][Full Text] [Related]
37. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
38. HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway.
Dai B; Yang T; Shi X; Ma N; Kang Y; Zhang J; Zhang Y
Phytomedicine; 2018 Dec; 51():48-57. PubMed ID: 30466627
[TBL] [Abstract][Full Text] [Related]
39. Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
Giralt I; Gallo-Oller G; Navarro N; Zarzosa P; Pons G; Magdaleno A; Segura MF; Sábado C; Hladun R; Arango D; Sánchez de Toledo J; Moreno L; Gallego S; Roma J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884726
[TBL] [Abstract][Full Text] [Related]
40. Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer.
Zhao H; Li J; Li X; Han C; Zhang Y; Zheng L; Guo M
Curr Protein Pept Sci; 2015; 16(4):316-21. PubMed ID: 25929866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
